Displaying items 39141-39160 of 42922 in total

The Peril of 'Flawless' Mergers: Primo Brands Faces Fraud Lawsuit

Read full article
The Peril of 'Flawless' Mergers: Primo Brands Faces Fraud Lawsuit

Balyasny's Derivative Play Signals High-Stakes Endgame for Spectris

Read full article
BriefGlance

Target's AI Holiday: The New Battleground for Digital Retail

Read full article
Target's AI Holiday: The New Battleground for Digital Retail

Natixis's Dual Play: Decoding a Complex Bet on the £1.2B Bakkavor Deal

Read full article
BriefGlance

FOSSiBOT's Power Play: A 7200W Challenger Enters the U.S. Market

Read full article
FOSSiBOT's Power Play: A 7200W Challenger Enters the U.S. Market

NATIXIS's Double Play in the £2.4 Billion Just Group Buyout

Read full article
BriefGlance

Canada's €408M Bet on ESA: A New Orbit for Tech, Markets, and Security

Read full article
Canada's €408M Bet on ESA: A New Orbit for Tech, Markets, and Security

Crypto's Social License: Bitget's $12M Hong Kong Fire Donation

Read full article
Crypto's Social License: Bitget's $12M Hong Kong Fire Donation

mesm Tokyo Fuses Tradition and Luxury for a Unique NYE Countdown

Read full article
mesm Tokyo Fuses Tradition and Luxury for a Unique NYE Countdown

The Arbitrage Art: Decoding Natixis’s Play in the Spectris Takeover

Read full article
BriefGlance

ECP’s £1.5B Power Play: Securing UK’s High-Life Infrastructure

Read full article
BriefGlance

Rubico's Reverse Split: A Lifeline or an Anchor for the Shipper?

Read full article
Rubico's Reverse Split: A Lifeline or an Anchor for the Shipper?

Apolosign’s Smart Bet: Building a Resilient Niche in Family Tech

Read full article
Apolosign’s Smart Bet: Building a Resilient Niche in Family Tech

Timber Turmoil: Conifex Curtailment Signals Deeper Industry Crisis

Read full article
Timber Turmoil: Conifex Curtailment Signals Deeper Industry Crisis

FOLFIRINOX: A Repurposed Chemotherapy Offers New Hope for Biliary Cancer

Read full article
FOLFIRINOX: A Repurposed Chemotherapy Offers New Hope for Biliary Cancer

Hangzhou's Playbook: How China is Winning the Global War for Talent

Read full article
BriefGlance

Cuprina's Nasdaq Countdown: Can Biotech Innovation Beat the Delisting Clock?

Read full article
Cuprina's Nasdaq Countdown: Can Biotech Innovation Beat the Delisting Clock?

Bayview's $1.3B Play: Forging a New Mortgage Market Powerhouse

Read full article
Bayview's $1.3B Play: Forging a New Mortgage Market Powerhouse

Smart Glasses in Canadian Warehouses: A New Industrial Reality

Read full article
Smart Glasses in Canadian Warehouses: A New Industrial Reality

CDG Bets on Home Devices to Build a Decentralized AI Cloud Network

Read full article
CDG Bets on Home Devices to Build a Decentralized AI Cloud Network